Skip to main content
European Commission logo
IP Helpdesk
  • Training and workshops

EU - From Lab to Market - Successful Technology Transfer Journeys - Case: Atlantic Therapeutics RECORDING

After the kick off and the first case, is this now the second concrete case of our successful technology transfer ventures. This event series is jointly organised by the EPO Academy and the European IP Helpdesk.

Each case study provides key takeaways for stakeholders in universities, other public research organisations and businesses. Overall, they demonstrate the importance of patents for technology transfer to start-ups, spin-offs and established companies.

  • intellectual property | technology transfer | quality of life
  • Wednesday 29 June 2022, 10:30 - 12:00 (CEST)
  • Live streaming available

Files

  • 26 APRIL 2022
Improving quality of life - EPO case Atlantic Therapeutics
English
(1.14 MB - PDF)
Download

Practical information

When
Wednesday 29 June 2022, 10:30 - 12:00 (CEST)
Languages
English
Organisers
European Innovation Council and SMEs Executive Agency
Website
RECORDING
Number of seats
1000 Participants
Entrance fee
This Webinar is offered free of charge

Description

Time: 10:30 am - 12:00 pm (CEST) - the webinar session will open 15 minutes before the official start

Host: European IP Helpdesk and EPO Academy

Expert: Ciaran O’Beirne, Head of Knowledge Transfer
Moderator: Stephanie Weber, Communication Manager, European IP Helpdesk

Level of Expertise: Intermediate

Case: Atlantic Therapeutics

Research collaboration between University College Dublin (UCD) and Bio‑Medical Research (BMR) led to the development of a novel training device for the treatment of stress-induced urinary incontinence. UCD licensed the technology to BMR, which validated the device in clinical trials, secured regulatory approval and launched it in Europe. BMR established Atlantic Therapeutics as a spin-out company to secure investment to target the US market. Atlantic Therapeutics, its flagship product, offers patients safe, non-invasive and cost-effective treatment for stress-induced urinary incontinence, improving the quality of lives.

Improving quality of life

  • In academy-industry collaborations, recognise all partners' needs and define incentives and criteria so that the company can act as the commercial partner.
  • A joint ownership management agreement is necessary to facilitate later commercialisation if joint foreground IP is anticipated.
  • The deal structure should always be benchmarked so that it is fair and reasonable and reflects industry norms.
  • Agree on key development and commercial milestones early, to guide and facilitate market success, but be willing to amend as necessary.

Fee: The webinar will be offered free of charge.

Assistance: For any technical assistance or questions, please contact the training team at: trainingatiprhelpdesk [dot] eu (training[at]iprhelpdesk[dot]eu)

    From Lab to Market